Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print MedImmune presents new data showing burden of RSV disease

MedImmune presents new data showing burden of RSV disease

May 06, 2009

MedImmune today announced results from a recent study it sponsored, performed by the Kaiser Permanente Division of Research in Oakland, CA, assessing risk factors for respiratory syncytial virus (RSV) infection requiring medical treatment in infants born at 33 weeks gestational age [GA] or later. The analysis suggested that even mild prematurity (e.g., babies born 33-36 weeks GA) is associated with increased risk of medically attended RSV infection, and that this risk is higher among infants exposed to supplemental oxygen or assisted ventilation during the neonatal period. These findings were presented at the 2009 Pediatric Academic Societies (PAS) Annual Meeting in Baltimore, Maryland by Dr. Gabriel J. Escobar.

RSV is a leading cause of viral respiratory infection among preterm infants. Although prematurity is a known risk factor for severe RSV infection, there is little information available on risk factors among moderately (rather than extremely) premature babies.




"The health risks associated with late-preterm birth may be overlooked or misunderstood because these babies often appear as healthy as full-term infants. This study contributes to the growing evidence that, late-preterm infants face greater morbidity and healthcare costs up to at least one year after birth," noted Parthiv Mahadevia, M.D., senior director, health outcomes and pharmacoeconomics, MedImmune. "In particular, babies born between 33 and 36 weeks GA have under-developed respiratory and immune systems, putting them at heightened risk for severe RSV disease. Doctors, parents, and the health care system should be aware of these babies' specialized health needs

This study sought to quantify the relationships between neonatal characteristics and the occurrence of RSV infection requiring medical attention in the first year of life.

The study consisted of 117,060 babies born at 33 weeks gestation or later, who were discharged from six hospitals between January 1, 1996, and December 31, 2002. The neonatal characteristics evaluated included GA, infant sex, "small for GA" status, oxygen exposure variables, and hospital discharge during the RSV season.

The authors noted that further research is needed to determine whether strategies to prevent or mitigate RSV infection are needed in late-preterm infants.

Edelman Public Relations



Related RSV Disease Current Events and RSV Disease News Articles
MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition
MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2009 National Conference & Exhibition that add to the company's growing body of research on the burden of respiratory syncytial virus (RSV) on children, as well as pediatric infectious disease prevention.

Neonatologists and pediatricians highlight progress and barriers to preemie care
A recent survey of 202 neonatologists and pediatricians, which examined current attitudes and practices when caring for the specialized health needs of preterm infants, revealed that most respondents (70 percent) feel the United States' healthcare system does not place enough emphasis on or dedicate enough resources to preventive healthcare for preemies.

Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
MedImmune, Inc. today announced results from two important studies presented at the 2007 Infectious Diseases Society of America (IDSA) 45th Annual Meeting adding to the body of knowledge about respiratory syncytial virus (RSV).
More RSV Disease Current Events and RSV Disease News Articles
  Controversies in infectious disease: one expert's picks: MRSA, RSV are hot.(Infectious Diseases)(methicillin-resistant Staphylococcus aureus)(respiratory ... virus): An article from: Pediatric News
by Heidi Splete (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on March 1, 2004. The length of the article is 872 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Controversies in infectious disease: one expert's picks: MRSA, RSV are hot.(Infectious Diseases)(methicillin-resistant Staphylococcus aureus)(respiratory syncytial virus)
Author: Heidi Splete
Publication: Pediatric News (Magazine/Journal)
Date: March 1, 2004
Publisher: International Medical News Group
Volume: 38 Issue: 3 Page: 15(1)

Distributed by Thomson...

  Infectious Disease Tests & Controls, RSV Tests - Viral Infection Tests & Control Sets -
by SA Scientific

These rapid diagnostic tests are designed to facilitate the detection of a variety of viral and bacterial infectious diseases. Three viral infection tests are available: adenovirus, which can detect all 41 known adenovirus strains; rotavirus, which can detect all rotavirus strains; and RSV, which can detect the respiratory syncytial virus. Controls to validate results must be purchased separately. Tests are conducted by adding specimen samples into sample wells and simply reading results, which are available within 15 minutes. The bacterial infection StrepAlert test provides an immunoassay for Strep A. Controls are included with this test. The procedure is conducted with a dipstick and provides results within five minutes.

  Metapneumovirus is major culprit in respiratory illness; in late winter/early spring as RSV disease wanes, metapneumovirus peaks: hints of future vaccine ... Diseases): An article from: Pediatric News
by Bruce Jancin (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on October 1, 2003. The length of the article is 832 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Metapneumovirus is major culprit in respiratory illness; in late winter/early spring as RSV disease wanes, metapneumovirus peaks: hints of future vaccine efficacy. (respiratory syncytial virus).(Infectious Diseases)
Author: Bruce Jancin
Publication: Pediatric News (Magazine/Journal)
Date: October 1, 2003
Publisher: International Medical News Group
Volume: 37 ...

  Palivizumab cuts RSV readmissions.(Infectious Diseases)(respiratory syncytial virus): An article from: Pediatric News
by Jeff Evans (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on October 1, 2004. The length of the article is 347 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Palivizumab cuts RSV readmissions.(Infectious Diseases)(respiratory syncytial virus)
Author: Jeff Evans
Publication: Pediatric News (Magazine/Journal)
Date: October 1, 2004
Publisher: International Medical News Group
Volume: 38 Issue: 10 Page: 11(1)

Distributed by Thomson...

  Investigational antibody effective against RSV.(Infectious Diseases)(respiratory syncytial virus)(motavizumab): An article from: Pediatric News
by Patrice Wendling (Author)

This digital document is an article from Pediatric News, published by Thomson Gale on August 1, 2007. The length of the article is 536 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Investigational antibody effective against RSV.(Infectious Diseases)(respiratory syncytial virus)(motavizumab)
Author: Patrice Wendling
Publication: Pediatric News (Magazine/Journal)
Date: August 1, 2007
Publisher: Thomson Gale
Volume: 41 Issue: 8 Page: 19(1)

Distributed by Thomson...

  Urban study uses follow-up care to prevent RSV.(Infectious Diseases): An article from: Pediatric News
by Bruce K. Dixon (Author)

This digital document is an article from Pediatric News, published by Thomson Gale on January 1, 2007. The length of the article is 466 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Urban study uses follow-up care to prevent RSV.(Infectious Diseases)
Author: Bruce K. Dixon
Publication: Pediatric News (Magazine/Journal)
Date: January 1, 2007
Publisher: Thomson Gale
Volume: 41 Issue: 1 Page: 23(1)

Distributed by Thomson...

Human Antibody Therapeutics For Viral Disease (Current Topics in Microbiology and Immunology)

Human Antibody Therapeutics For Viral Disease (Current Topics in Microbiology and Immunology)
by Scott K. Dessain (Editor)

Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to be realized for the treatment of viral infectious diseases. Polyclonal immunoglobulins have long been used for some viral diseases, but they have limited potency and disease scope. It should theoretically be possible to create monoclonal or oligoclonal antibody preparations that capture the essential curative functions of the humoral immune response to viral pathogens, yet only a single humanized monoclonal antibody (pavilizumab) has been approved as a viral countermeasure. Reliable technologies for creating human or humanized antibodies with defined viral antigen specificities are well-established. Accordingly, current antibody development...

  Palivizumab safely prevents RSV in infantile CHD.(AAP revises drug indications)(respiratory syncytial virus )(congenital heart disease): An article from: Pediatric News
by Damian McNamara (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on July 1, 2004. The length of the article is 561 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Palivizumab safely prevents RSV in infantile CHD.(AAP revises drug indications)(respiratory syncytial virus )(congenital heart disease)
Author: Damian McNamara
Publication: Pediatric News (Magazine/Journal)
Date: July 1, 2004
Publisher: International Medical News Group
Volume: 38 Issue: 7 Page: NA

Distributed by Thomson...

  Serious bacterial infections unusual in young infants with RSV and fever: full sepsis evaluation unnecessary? (Infectious Diseases).(respiratory syncytial virus): An article from: Pediatric News
by Doug Brunk (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on July 1, 2003. The length of the article is 921 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Serious bacterial infections unusual in young infants with RSV and fever: full sepsis evaluation unnecessary? (Infectious Diseases).(respiratory syncytial virus)
Author: Doug Brunk
Publication: Pediatric News (Magazine/Journal)
Date: July 1, 2003
Publisher: International Medical News Group
Volume: 37 Issue: 7 Page: 15(1)

Distributed by Thomson...

  RSV-Apnea linkage may be overrated.(News): An article from: Pediatric News
by Betsy Bates (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on October 1, 2008. The length of the article is 706 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: RSV-Apnea linkage may be overrated.(News)
Author: Betsy Bates
Publication: Pediatric News (Magazine/Journal)
Date: October 1, 2008
Publisher: International Medical News Group
Volume: 42 Issue: 10 Page: 1(2)

Distributed by Gale, a part of Cengage...

© 2009 BrightSurf.com